Totus Medicines
Cambridge
About Totus Medicines
Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome. Leveraging its groundbreaking platform, Totus Medicines can simultaneously screen billions of drug candidates against thousands of targets, identifying superior molecules. This includes candidates for traditionally challenging, undruggable targets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $106.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2023)
- Website: totusmedicines.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/totus-medicines-43846 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.